Ownership history in Bayesian Capital Management, LP Β· 13 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in INTUITIVE SURGICAL INC (ISRG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Bayesian Capital Management, LP outperformed the S&P 500 by +35.7% annually on this ISRG position. Timing score: 50% (6/12 decisions correct). Average cost basis: $324.06. Maximum drawdown during holding period: β16.6%.
π₯ Exceptional β beat the S&P 500 by 35.7% per year on this position.
12 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
6 of 12 add/trim decisions correct
Best entry: $60.68 (2015 Q4) Β· Worst: $447.23 (2025 Q3)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
8 adds Β· 5 trims. Bought during 3 of 5 down-price quarters. π More buys than sells across the holding period.
π Portfolio weight has been declining in recent quarters. Possible distribution phase.
Currently 0.21% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size